Quote | Addex Therapeutics Ltd (NASDAQ:ADXN)
Last: | $8.10 |
---|---|
Change Percent: | -0.12% |
Open: | $8.02 |
Close: | $8.10 |
High: | $8.18 |
Low: | $8.02 |
Volume: | 700 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
News | Addex Therapeutics Ltd (NASDAQ:ADXN)
2024-07-19 15:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 17:52:22 ET More on Addex Therapeutics Addex Therapeutics Ltd (ADXN) Q1 2024 Earnings Call Transcript Addex stock plunges 50% on failed study for epilepsy drug Historical earnings data for Addex Therapeutics Financial information for Addex Therapeu...
Message Board Posts | Addex Therapeutics Ltd (NASDAQ:ADXN)
Subject | By | Source | When |
---|---|---|---|
Watch for this to have its days, low | harry crumb | investorshub | 05/11/2023 1:00:53 AM |
The float is already traded... big boom ahead imo | Klinsmann | investorshub | 05/10/2023 10:46:10 AM |
Addex Announces ADX71149 Phase 2 Epilepsy Clinical Studys | subslover | investorshub | 05/10/2023 9:59:36 AM |
Price trading up | glenn1919 | investorshub | 05/09/2023 3:35:34 AM |
$ADXN MomentumIts gaining | willlbone | investorshub | 05/07/2023 8:43:30 AM |
News, Short Squeeze, Breakout and More Instantly...
Addex Therapeutics Ltd Company Name:
ADXN Stock Symbol:
NASDAQ Market:
Addex Therapeutics Ltd Website:
2024-07-19 15:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 15, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological...
Geneva, Switzerland, July 12, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that Mikhail Kalinichev, Head of T...